| Serial Number | 98256350 |
| Word Mark | ACCESS DAXXIFY |
| Filing Date | Monday, November 6, 2023 |
| Status | 688 - NOTICE OF ALLOWANCE - ISSUED |
| Status Date | Tuesday, September 17, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, July 23, 2024 |
| Goods and Services | Business administration of patient reimbursement programs; Business management of reimbursement programs for others |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, December 1, 2023 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Revance Therapeutics, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Newark, CA 94560 |
| Party Name | Revance Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Newark, CA 94560 |
| Event Date | Event Description |
| Thursday, November 9, 2023 | NEW APPLICATION ENTERED |
| Friday, December 1, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, July 23, 2024 | PUBLISHED FOR OPPOSITION |
| Friday, June 14, 2024 | ASSIGNED TO EXAMINER |
| Monday, June 17, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, July 3, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, September 17, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, July 23, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |